Advertisement
Canada markets close in 53 minutes
  • S&P/TSX

    21,982.33
    +96.95 (+0.44%)
     
  • S&P 500

    5,108.51
    +60.09 (+1.19%)
     
  • DOW

    38,291.99
    +206.19 (+0.54%)
     
  • CAD/USD

    0.7323
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.76
    +0.19 (+0.23%)
     
  • Bitcoin CAD

    87,384.03
    -1,013.05 (-1.15%)
     
  • CMC Crypto 200

    1,332.95
    -63.59 (-4.55%)
     
  • GOLD FUTURES

    2,352.10
    +9.60 (+0.41%)
     
  • RUSSELL 2000

    2,003.62
    +22.51 (+1.14%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,943.81
    +332.05 (+2.13%)
     
  • VOLATILITY

    15.05
    -0.32 (-2.08%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Why Tilray Stock Dropped in April

Why Tilray Stock Dropped in April

Canadian cannabis company Tilray (NASDAQ: TLRY) hasn't reported first quarter 2021 financial results yet, but another earnings report in April had an immediate impact on Tilray stock. Canadian peer Aphria reported its financial update on April 12, and disappointed investors sold off Tilray stock, too, knocking it down 13% on the day. The newly combined company using the Tilray name is being led by former Aphria CEO Irwin Simon.